Completed PHASE3 NCT00003162

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Randomized Trial of Palliative Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life

Sponsor: National Cancer Institute (NCI)

Conditions Breast Cancer Metastatic Cancer Pain Prostate Cancer

Interventions pain therapy radiation therapy

Updated 6 times since 2017 Last updated: Nov 14, 2015 Started: Feb 28, 1998 Primary completion: Jul 31, 2003

This PHASE3 trial investigates Breast Cancer and Metastatic Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 6 recorded versions since 1998 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
North Central Cancer Treatment Group
Radiation Therapy Oncology Group

Data source: Radiation Therapy Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Albany, United States , Albuquerque, United States , Allentown, United States , Amarillo, United States , Anderson, United States , Ann Arbor, United States , Annapolis, United States , Arlington Heights, United States , Atlanta, United States and 183 more locations